Томский политехнический университет, Liu Yongsheng, Xu Tianqi, Vorobjeva A. G. Anzhelika Grigorjevna, Loftenius Annika, Bodenko V. V. Vitalina Vasiljevna, . . . Tolmachev V. M. Vladimir Maksimilianovich. (2023). Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab; Cancers; Vol. 15 - iss. 9. 2023. https://doi.org/10.3390/cancers15092409
শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতিТомский политехнический университет, Liu Yongsheng, Xu Tianqi, Vorobjeva A. G. Anzhelika Grigorjevna, Loftenius Annika, Bodenko V. V. Vitalina Vasiljevna, Orlova A. M. Anna Markovna, Frejd Y. F. Fredrik, এবং Tolmachev V. M. Vladimir Maksimilianovich. Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab; Cancers; Vol. 15 - Iss. 9. 2023, 2023. https://doi.org/10.3390/cancers15092409.
M.L.A (9 ম সংস্করণ) উদ্ধৃতিТомский политехнический университет, et al. Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab; Cancers; Vol. 15 - Iss. 9. 2023, 2023. https://doi.org/10.3390/cancers15092409.